Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma

Cite this paper

@inproceedings{Feldman2014AdditionOL, title={Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma}, author={Tatyana A Feldman and Anthony R Mato and Kar Fai Chow and Ewelina A Protomastro and Kara M L Yannotti and Pritish Bhattacharyya and Xiao Yang and Michele L Donato and Scott D. Rowley and Carolanne Carini and Marisa Valentinetti and Judith M. Smith and Gabriella Gadaleta and Coleen Bejot and Susan Stives and Mary Timberg and Sabrina Kdiry and A. Pecora and Anne W Beaven and Andre Goy}, booktitle={British journal of haematology}, year={2014} }